ArcBest (ARCB.O): ARCB 2Q: Post-earnings sell-off reflects liability fears, overlooks core improvement; add 90-day upside ST view

Research evidence excerpt

ArcBest (ARCB.O): ARCB 2Q: Post-earnings sell-off reflects liability fears, overlooks core improvement; add 90-day upside ST view

Action |

04 Aug 2026 00:27:06 ET │ 16 pages

ArcBest (ARCB.O)

ARCB 2Q: Post-earnings sell-off reflects liability fears, overlooks core

improvement; add 90-day upside ST view

CITI'S TAKE

ARCB reported 2Q26 adj. EPS of $2.38, up +75% y-y, above Citi/Street’s Buy

$2.01/$2.26 estimates. Somewhat confoundingly, shares sold-off post-

earnings (down -8% since reporting), and are down -20% from their recent Short-Term View: Upside

peak in June, despite solidly beating estimates, coupled with upward Price (03 Aug 26 16:00) US$137.57

revisions to sell-side targets beyond 2Q. We believe part of this pressure Target price US$171.00↓reflects concerns over the Montgomery fallout and liability associated with

ArcBest’s asset-light brokerage operations. While we share these concerns, from US$178.00

we believe ArcBest benefits from its asset-based LTL business such that its Expected share price return 24.3%

liability is less of a concern than a pure-play broker. At the same time, core

Expected dividend yield 0.3%improvements to its operations, including its recently announced

restructuring, offer medium-term upside (anticipated $40m/yr savings or Expected total return 24.6%

+$1.40 EPS), which the Street seems to be increasingly recognizing as Market Cap US$3,075M

‘27e/’28e adj. EPS targets have move higher. We add a positive ST view as

we see share price upside and multiple re-rating potential.

Fundamentals — ArcBest’s solid 2Q results were led by an impressive 660bps of Price Performance

sequential margin improvement in its Asset-Based LTL segment, posting a 90.8%

(RIC: ARCB.O, BB: ARCB US)adj. operating ratio (better than our 91.2% target).